SenzaGen’s Newsletter Q2 2025
Click image to view the Newsletter in browser. SenzaGen Newsletter 2025 Q2 GARD®skin is now included in OECD TG 497 We are excited to announce that the GARDskin assay (OECD TG […]
Entries by Julia Li
Published report by NICEATM: Evaluation of the GARDskin Sensitization Test Method Using Substances of Regulatory Interest
NICEATM’s report confirms the inclusion of GARDskin improved the overall performance of the Defined Approaches for Skin Sensitization (DASS) The recent published report by NICEATM* summarizes an evaluation of the […]
SenzaGen’s Newsletter Q1 2025
Click image to view the Newsletter in browser. Text-only version: Scientific highlights from SOT 2025 SOT 2025 in Orlando was a fantastic opportunity to connect with industry leaders and present the […]
Joint poster with Lundbeck: Case study on Occupational Health and Safety
Assessing Skin Sensitizing Hazard of Drug Products and Active Pharmaceutical Ingredients using GARD®: New Approach Methodology in Occupational Health and Safety Presented at 2025 SOT Download a copy in PDF […]
Poster: Skin sensitization potency classification according to GHS/CLP
Subcategorization of skin sensitizers into UN GHS categories using GARDskin Dose-Response Presented at 2025 SOT Download a copy in PDF Conclusion GARD®skin Dose-Response provides accurate and robust UN GHS […]
SenzaGen at 2025 SOT: Advancing NAMs for Skin Sensitization Testing
The SenzaGen team had a fantastic time at SOT this year in Orlando, connecting with peers and presenting the latest GARD® data from our industry collaborations. A special thank you […]
Joint publication with RIFM and IFF: Determining a Point of Departure for Skin Sensitization Potency and Quantitative Risk Assessment of Fragrance Ingredients Using the GARD®skin Dose-Response Assay
Advancing NAMs for Fragrance Safety: Collaborative Research with RIFM and IFF. As innovators in in vitro skin sensitization testing, addressing key data gaps, we are pleased to share the publication […]
SenzaGen’s Newsletter Dec 2024
Click image to view the Newsletter in browser. Text-only version: SenzaGen’s Newsletter Dec 2024 As 2024 ends: We’re proud to share how our innovative GARD® method is addressing key challenges in […]
